Avelox Abc Pack
Product Images NDC 16590-881

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Avelox Abc Pack (NDC 16590-881). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Image (Aveloxabc400mg Struct)

Chemical structure of the active ingredient in Avelox ABC Pack, showing a complex fused ring system with fluorine, oxygen, nitrogen atoms, and a carboxylic acid group, including a cyclopropyl group and substitution with hydrochloride (HCl).*

FDA Label Image

Figure 1 (Aveloxabc Fig1)

A pharmacokinetic curve showing plasma concentration (µg/mL) over time (hours) comparing oral and intravenous (i.v.) doses. The graph plots concentration levels from 0 to 28 hours, indicating how plasma concentration changes after administration via oral and i.v. routes.*

FDA Label Image

Label Image (Aveloxabc Label)

Label for Avelox ABC Pack, containing 400 mg tablets with 5 tablets per package. The product is distributed by Stat Rx USA and manufactured by Schering-Plough Corp. It contains moxifloxacin HCl equivalent to 400 mg of moxifloxacin per tablet. The label includes storage instructions, a caution about drowsiness or dizziness, and an instruction to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.